143 related articles for article (PubMed ID: 16478797)
1. Heterogeneity of metallo-beta-lactamases in clinical isolates of Chryseobacterium meningosepticum from Hangzhou, China.
Chen GX; Zhang R; Zhou HW
J Antimicrob Chemother; 2006 Apr; 57(4):750-2. PubMed ID: 16478797
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of bla(IND) metallo-beta-lactamase-producing Chryseobacterium indologenes isolates detected in Hefei, China.
Lin XH; Xu YH; Cheng J; Li T; Wang ZX
Int J Antimicrob Agents; 2008 Nov; 32(5):398-400. PubMed ID: 18707850
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
Chang TY; Chen HY; Chou YC; Cheng YH; Sun JR
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2045-2052. PubMed ID: 31352669
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea.
Yum JH; Lee EY; Hur SH; Jeong SH; Lee H; Yong D; Chong Y; Lee EW; Nordmann P; Lee K
J Microbiol; 2010 Jun; 48(3):358-64. PubMed ID: 20571954
[TBL] [Abstract][Full Text] [Related]
5. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
Kim SY; Hong SG; Moland ES; Thomson KS
J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity analyses of antimicrobial resistance genes in clinical Chryseobacterium meningosepticum isolated from Hefei, China.
Lin XH; Xu YH; Sun XH; Huang Y; Li JB
Int J Antimicrob Agents; 2012 Aug; 40(2):186-8. PubMed ID: 22612901
[No Abstract] [Full Text] [Related]
7. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.
Bellais S; Aubert D; Naas T; Nordmann P
Antimicrob Agents Chemother; 2000 Jul; 44(7):1878-86. PubMed ID: 10858348
[TBL] [Abstract][Full Text] [Related]
8. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F
J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
10. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
Loli A; Tzouvelekis LS; Tzelepi E; Carattoli A; Vatopoulos AC; Tassios PT; Miriagou V
J Antimicrob Chemother; 2006 Sep; 58(3):669-72. PubMed ID: 16870645
[TBL] [Abstract][Full Text] [Related]
11. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
[TBL] [Abstract][Full Text] [Related]
12. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Martins AF; Zavascki AP; Gaspareto PB; Barth AL
Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
[TBL] [Abstract][Full Text] [Related]
13. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae.
Galani I; Rekatsina PD; Hatzaki D; Plachouras D; Souli M; Giamarellou H
J Antimicrob Chemother; 2008 Mar; 61(3):548-53. PubMed ID: 18222954
[TBL] [Abstract][Full Text] [Related]
16. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
[TBL] [Abstract][Full Text] [Related]
17. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.
Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y
Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406
[TBL] [Abstract][Full Text] [Related]
18. Investigation of metallo-beta-lactamase producing strains of Pseudomonas aeruginosa and Acinetobacter baumannii by E-test, disk synergy and PCR.
Aktaş Z; Kayacan CB
Scand J Infect Dis; 2008; 40(4):320-5. PubMed ID: 17934980
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-beta-lactamases in gram-negative bacilli.
Yan JJ; Wu JJ; Tsai SH; Chuang CL
Diagn Microbiol Infect Dis; 2004 May; 49(1):5-11. PubMed ID: 15135493
[TBL] [Abstract][Full Text] [Related]
20. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
